Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
about
Dexmedetomidine use in pediatric intensive care and procedural sedation.Pain management in newborns.Effects of Clonidine on Withdrawal From Long-term Dexmedetomidine in the Pediatric Patient.Dexmedetomidine for Sedation during Withdrawal of Support.Effects of dexmedetomidine versus propofol on SPO2 in children with tetralogy of fallot during anesthesiaSafety and Effectiveness of Dexmedetomidine in the Pediatric Intensive Care Unit (SAD-PICU).A dose-response study of dexmedetomidine administered as the primary sedative in infants following open heart surgery.Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.Dexmedetomidine: pediatric pharmacology, clinical uses and safety.Dexmedetomidine hydrochloride as a long-term sedative.Safety and efficacy of dexmedetomidine in children with heart failure.Intensive care and perioperative management of patients with complete atrioventricular septal defect.Dexmedetomidine Use in Critically Ill Children With Acute Respiratory Failure.Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates.Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate.Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease.Dexmedetomidine utilisation and outcomes of children with trisomy 21 undergoing congenital heart disease surgery.Prolonged Dexmedetomidine Infusion and Drug Withdrawal In Critically Ill Children.Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury.
P2860
Q30433461-549D72D9-1B75-4F43-B7AC-78F2CE21C6F7Q34625140-AC6ABA6A-9797-441F-BD34-750FFB544A16Q35157966-AC58DFE3-4753-40CD-93B8-B6DA999DDA3AQ36000694-E5FE711B-6465-4F1B-A807-4C9FF48CE773Q36511623-B2A7F657-BFF6-4291-BA80-325E975A0227Q36643320-9A5684F7-FCA8-4D2E-B91D-8C827DE006E1Q37038596-7AF3458B-B27C-4B3C-9F3B-A76F1416DD04Q37090515-A91BB5C2-C2E1-4389-9DF5-22EDA06D7C71Q37780765-7DB22845-0EFC-4F3D-8624-5CCA7A6050DEQ37918360-49E2A5E8-C5F5-4EC6-88B0-EDF79A9D3CFCQ38050965-8B0E0312-C3BB-4545-9F87-DB9C8378BF83Q38117328-EEA30F62-5BC4-4E60-A67F-EEE64B58070EQ39365412-C2E9F951-D04E-4FE5-9B5C-B6DE5E571494Q42422393-A0BFA81C-6033-4E46-98DF-3FC918D0864EQ43276347-048FF885-0A9B-41FA-97DA-095CAE880BDEQ44756332-D12F7479-86F7-421A-96E0-EA91998C5481Q44805815-8A624552-6A3E-4330-8389-D89B03093345Q54950709-D689A53C-7B66-4A27-977D-AD9653E75F7CQ55387407-11CE480A-FF5B-4073-A9CE-EEB9E0F89534
P2860
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
@en
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
@nl
type
label
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
@en
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
@nl
prefLabel
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
@en
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
@nl
P2093
P2860
P1476
Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
@en
P2093
Brigham C Willis
Cassie Valasek
David C Cleveland
John J Nigro
Sharon Bejian
P2860
P304
P356
10.1017/S1047951109003515
P577
2009-01-20T00:00:00Z